BioSig Technologies Inc (NASDAQ:BSGM) shares rose 7.2% during mid-day trading on Wednesday . The stock traded as high as $6.88 and last traded at $6.83. Approximately 148,123 shares were traded during trading, an increase of 16% from the average daily volume of 127,798 shares. The stock had previously closed at $6.37.
BSGM has been the topic of several research reports. Laidlaw set a $11.00 price objective on BioSig Technologies and gave the stock a “buy” rating in a report on Wednesday, February 20th. Zacks Investment Research downgraded BioSig Technologies from a “hold” rating to a “sell” rating in a report on Tuesday, April 16th.
The company has a quick ratio of 10.99, a current ratio of 10.99 and a debt-to-equity ratio of 0.02.
In other BioSig Technologies news, CEO Kenneth L. Londoner bought 6,000 shares of the company’s stock in a transaction on Thursday, May 23rd. The stock was bought at an average price of $6.88 per share, for a total transaction of $41,280.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Kenneth L. Londoner bought 15,000 shares of the company’s stock in a transaction on Monday, May 20th. The shares were acquired at an average price of $7.78 per share, with a total value of $116,700.00. The disclosure for this purchase can be found here. In the last ninety days, insiders have acquired 40,150 shares of company stock worth $289,165. Company insiders own 26.70% of the company’s stock.
Institutional investors have recently modified their holdings of the business. Deutsche Bank AG bought a new stake in shares of BioSig Technologies during the 4th quarter valued at $58,000. Morgan Stanley raised its position in shares of BioSig Technologies by 212.1% during the 1st quarter. Morgan Stanley now owns 11,547 shares of the company’s stock valued at $71,000 after acquiring an additional 7,847 shares during the last quarter. Northern Trust Corp bought a new stake in shares of BioSig Technologies during the 1st quarter valued at $80,000. BlackRock Inc. bought a new stake in shares of BioSig Technologies during the 1st quarter valued at $365,000. Finally, Cornerstone Wealth Group LLC bought a new stake in shares of BioSig Technologies during the 1st quarter valued at $368,000. Institutional investors own 4.87% of the company’s stock.
About BioSig Technologies (NASDAQ:BSGM)
BioSig Technologies, Inc, a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures.
Featured Article: What is a blue-chip stock?
Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.